Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment

scientific article published on 29 November 2010

Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.TAAP.2010.11.011
P8608Fatcat IDrelease_snmssxy5kngnbhqum5ncppbbsi
P698PubMed publication ID21122807
P5875ResearchGate publication ID49650046

P50authorNúria RoglansQ39930233
Marta AlegretQ39930276
Juan C. LagunaQ42110233
Manuel MerlosQ42317567
Laia VilàQ51530778
Alba RebolloQ117258205
P2093author name stringGunnar S Ađalsteisson
P433issue1
P304page(s)32-40
P577publication date2010-11-29
P1433published inToxicology and Applied PharmacologyQ2446974
P1476titleReduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment
P478volume251

Reverse relations

cites work (P2860)
Q41682321A specific Streptococcus mutans strain aggravates non-alcoholic fatty liver disease
Q98178483An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
Q48273811Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks.
Q53731402Development and optimisation of atorvastatin calcium loaded self-nanoemulsifying drug delivery system (SNEDDS) for enhancing oral bioavailability: in vitro and in vivo evaluation.
Q39044073Dietary fructose as a risk factor for non-alcoholic fatty liver disease (NAFLD).
Q88324997Effect of high chronic intake of sucrose on liver metabolism in aging rats. Modulation by rutin and micronutrients
Q36914719Fructose, but not glucose, impairs insulin signaling in the three major insulin-sensitive tissues
Q36114134Fructose-induced increases in expression of intestinal fructolytic and gluconeogenic genes are regulated by GLUT5 and KHK.
Q39632594Fsp27/CIDEC is a CREB target gene induced during early fasting in liver and regulated by FA oxidation rate.
Q34728267Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies
Q36214543Opposite fates of fructose in the development of metabolic syndrome
Q37615131Relevance of a Hypersaline Sodium-Rich Naturally Sparkling Mineral Water to the Protection against Metabolic Syndrome Induction in Fructose-Fed Sprague-Dawley Rats: A Biochemical, Metabolic, and Redox Approach.
Q37999116Review article: fructose in non-alcoholic fatty liver disease
Q26864513Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insight
Q85911000The influence of Selank on the parameters of the hemostasis system, lipid profile, and blood sugar level in the course of experimental metabolic syndrome
Q33852213Toxic AGE (TAGE) Theory for the Pathophysiology of the Onset/Progression of NAFLD and ALD
Q46570814Type of supplemented simple sugar, not merely calorie intake, determines adverse effects on metabolism and aortic function in female rats
Q36450525Way back for fructose and liver metabolism: bench side to molecular insights

Search more.